J Thorac Cardiovasc Surg 2009;138:240-241
© 2009 The American Association for Thoracic Surgery
Surgical resection of resectable thoracic metastatic hepatocellular carcinoma after liver transplantation
Chong Zhang, MD,
Jian Rao, MD,
Zhengliang Tu, MD,
Yiming Ni, MD*
Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Received for publication February 23, 2008; accepted for publication May 4, 2008.
* Address for reprints: Yiming Ni, MD, Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China. (Email: haiyanzhangchong@163.com).
| The first 20% of the full text of this article appears below. |
 |
Introduction
|
|---|
Although the role of orthotopic liver transplantation (OLT) in the treatment of hepatocellular carcinoma (HCC) has improved over the years, tumor recurrence is still a major imitation of long-term survival even after radical transplantation treatment.1
Thoracic metastasis is the most common site of extrahepatic spreads. The role of surgery for thoracic metastasis is not known, and until now there have been few reports about surgical resection for thoracic HCC metastasis after liver transplantation. We evaluate the surgical efficacy in the treatment of thoracic HCC recurrence after OLT.
 |
Clinical Summary
|
|---|
Between October of 2003 and September of 2007, 5 patients who had undergone OLT for HCC demonstrated resectable thoracic HCC recurrence and were admitted to the Department of Thoracic and Cardiovascular Surgery without other identifiable recurrence foci. Thoracic recurrence was located in the right lower lobe and the upper lobe in 1 patient, the . . . [Full Text of this Article]
Copyright © 2009 by The American Association for Thoracic Surgery.